anonymous
Guest
anonymous
Guest
How deep does the IMS merger needs to go before QuintilesIMS divests the R&D element and drops being a CRO from their portfolio?
R&D is looking more and more like a pure-Novella org these days, so it may have value to be sold as such or as an independent company.
R&D is looking more and more like a pure-Novella org these days, so it may have value to be sold as such or as an independent company.